Ab Studio Inc. is a San Francisco Bay Area biotech startup founded in 2017 by its founder, Yue Liu, Ph.D., a leading scientist with extensive expertise in therapeutic antibody discovery and computer-aided design. Joining Yue, the team is composed of experts in antibody engineering, B-cell cloning, cancer biology, immunology, and virology.
Ab Studio enables the discovery and design of complex antibodies that include multispecific antibodies, imbalanced antibodies, serial internalizing antibodies, and catabodies. Using computer-aided antibody design (CAAD) platforms and traditional methods (hybridoma, phage display, and B-cell cloning) for rapid development, the company provides expertise in antibody design and optimization, which has led to promising clinical programs from both out-licensed assets and CRO projects.